Barclays analyst Raimo Lenschow upgrades Snowflake (NYSE:SNOW) from Equal-Weight to Overweight.
Alzamend Neuro Adds Healthy Subjects to Ongoing Mid-Stage Alzheimer’s Trial
Alzamend Neuro Inc (NASDAQ:ALZN) has dosed its first healthy adult subject in its Phase 2A multiple ascending dose (MAD) study of…